These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6672805)

  • 1. [Procainamide in renal failure].
    Ochotny R; Michałowska D; Lowicki Z; Chmara E
    Pol Tyg Lek; 1983 Oct; 38(41):1281-3. PubMed ID: 6672805
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure.
    du Souich P; Erill S
    Eur J Clin Pharmacol; 1978 Nov; 14(1):21-7. PubMed ID: 729603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmocodynamics of lividomycin in renal failure.
    Fillastre JP; Humbert G; Daufresne MF; Dubois D; Leroy A
    Proc Eur Dial Transplant Assoc; 1973; 10(0):547-50. PubMed ID: 4802558
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen kinetics in chronic renal failure of various causes.
    Ardaillou N; Sraer JD; Beaufils P
    Biomedicine; 1974 Jan; 21(1):49-56. PubMed ID: 4844175
    [No Abstract]   [Full Text] [Related]  

  • 5. [Doxycycline pharmacokinetics in chronic kidney failure patients treated by hemodialysis].
    Słuczanowski W
    Ann Acad Med Stetin; 1981; 27():313-30. PubMed ID: 7345952
    [No Abstract]   [Full Text] [Related]  

  • 6. Resin hemoperfusion for severe N-acetylprocainamide toxicity in patients with renal failure.
    Raja R; Kramer M; Alvis R; Goldstein S; DeLosAngeles A
    Trans Am Soc Artif Intern Organs; 1984; 30():18-20. PubMed ID: 6085435
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)].
    Schmidt P; Korn A; Hitzenberger G; Zazgornik J; Kopsa H; Pils P
    Wien Med Wochenschr; 1980 Feb; 130(4):171-3. PubMed ID: 7376686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
    Balant L; Gorgia A; Marmy A; Tschopp JM
    Nephrologie; 1980; 1(4):177-82. PubMed ID: 6895408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
    Drinovec J; Mrhar A; Bren A; Primozic S; Karba R; Varl J; Kozjek F
    J Chemother; 1989 Jul; 1(4 Suppl):565-6. PubMed ID: 16312534
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma half disappearance time and metabolic clearance rate of exogenous LH-RH in patients with chronic renal failure.
    Gryczyńska M; Kosowicz J; Czekalski S
    Mater Med Pol; 1980; 12(1-2):124-8. PubMed ID: 7035762
    [No Abstract]   [Full Text] [Related]  

  • 12. Mannitol intoxication in patients with renal failure.
    Borges HF; Hocks J; Kjellstrand CM
    Arch Intern Med; 1982 Jan; 142(1):63-6. PubMed ID: 6797362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peroral sorbents in the treatment of chronic renal failure].
    Shostka GD; Riabov SI; Lukichev BG; Strelko VV; Spiridonov VN
    Ter Arkh; 1984; 56(7):58-63. PubMed ID: 6484837
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of type of dialyzer on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):197-202. PubMed ID: 6862725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An unusual case of a side effect. Cefotaxime-induced confusion in a patient with renal failure].
    Brink B; Kimland E; von Euler M
    Lakartidningen; 2003 Jul; 100(28-29):2370-1. PubMed ID: 12899029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical pharmacology of procainamide and its active metabolite -N-acetylprocainamide].
    Matusewicz W; Orszulak DE
    Przegl Lek; 1984; 41(5):379-83. PubMed ID: 6206523
    [No Abstract]   [Full Text] [Related]  

  • 17. Piretanide: effective diuretic in renal failure.
    George CR
    Med J Aust; 1981 Jan; 1(2):83-4. PubMed ID: 7015088
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of methandrostenolone in chronic renal insufficiency].
    Timoner J; Melo E; Genta E; Goussinsky M; Shnaider J; Wajchenberg BL; Mattar E
    Rev Hosp Clin Fac Med Sao Paulo; 1967; 22(2):95-9. PubMed ID: 5602195
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetics of isoniazid in chronic kidney failure].
    Titarenko OT; Vakhmistrova TI; Perova TL; Morozov NV
    Vrach Delo; 1983 Apr; (4):19-22. PubMed ID: 6868525
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advantages of insulin Lispro (short-acting) in terminal kidney failure].
    Jehle PM; Aisenpreis U; Bundschu D; Keller F
    Fortschr Med; 1999 Apr; 117(11):41-2. PubMed ID: 10339922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.